Literature DB >> 31146853

What's new in reprocessing endoscopes: Are we going to ensure "the needs of the patient come first" by shifting from disinfection to sterilization?

William A Rutala1, Hajime Kanamori2, Emily E Sickbert-Bennett3, David J Weber3.   

Abstract

Millions of gastrointestinal endoscopes are performed each year in the United States. Gastrointestinal endoscopes become highly contaminated during use (ie, internal channels contain 7-10-log10 enteric microorganisms). Currently, endoscopes (eg, bronchoscopes and gastrointestinal endoscopes) are classified as semicritical items because they contact intact mucous membranes and most commonly undergo cleaning followed by high-level disinfection, which may result in as little as a 6-log10 reduction of microorganisms. Therefore, and not surprisingly, in recent years there have been multiple reports that have documented that endoscopes, especially duodenoscopes, frequently remain contaminated with bacterial pathogens after proper cleaning and disinfection. Multiple outbreaks of multidrug-resistant organisms from contaminated duodenoscopes have resulted in substantial death and morbidity. Because duodenoscopes commonly contact nonintact mucous membranes and sterile tissue, such endoscopes should be considered critical items. We propose that to ensure patient safety, we follow the Spaulding scheme and move from high-level disinfection to sterilization of reusable endoscopes or use an alternative diagnostic/therapeutic method (eg, disposable sterile endoscopes).
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Infection; Instrument reprocessing; Patient safety; high-level disinfection

Year:  2019        PMID: 31146853     DOI: 10.1016/j.ajic.2019.01.017

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  3 in total

1.  Rate and impact of duodenoscope contamination: A systematic review and meta-analysis.

Authors:  Sara Larsen; Rasmus Vinther Russell; Lotte Klinten Ockert; Stephen Spanos; Helena Strømstad Travis; Lars Holger Ehlers; Anders Mærkedahl
Journal:  EClinicalMedicine       Date:  2020-07-15

Review 2.  New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility.

Authors:  David J Weber; Emily E Sickbert-Bennett; Hajime Kanamori; William A Rutala
Journal:  Am J Infect Control       Date:  2019-06       Impact factor: 2.918

3.  The hidden cost of colonoscopy including cost of reprocessing and infection rate: the implications for disposable colonoscopes.

Authors:  Sara Larsen; Anthony Kalloo; Susan Hutfless
Journal:  Gut       Date:  2019-08-14       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.